Takao Honda

Investor profile

Takao Honda

Corporate VC & Senior Director, Lilly New Ventures, Asia at Eli Lilly and Company

Takao Honda is a Senior Director, Lilly New Ventures, Asia at Eli Lilly and Company, whose known portfolio counts 19 companies.

Is Takao Honda a fit for your startup?

Paste your website. AI checks the fit and scores every other investor too.

Investment focus

Contacts

LinkedIn profile on fileAvailable after registration.
Get contact

Affiliated funds' portfolios

Senior Director, Lilly New Ventures, Asia at Eli Lilly and Company, whose known portfolio counts 19 companies

  • Haya Therapeutics
  • Arda Therapeutics
  • Strand Therapeutics
  • TRex Bio
  • Aktis Oncology
  • Elektrofi
  • Zephyr AI
  • Ajax Therapeutics
  • Artax Biopharma
  • Circle Pharma
  • Sunbird Bio
  • Amprion
  • and 7 more

Investor Profile

Founders in the listed sectors AI and Healthcare, and focus areas Biotech, Drug Discovery, Genomics and Machine Learning fall inside that listing.

Stage-wise, the deals at Eli Lilly and Company cluster around Growth, Late-Stage and Seed rounds.

The firm portfolio and the focus above give founders context on whether Takao Honda matches their raise.

Colleagues at Eli Lilly and Company

Showing 20 of 23

Frequently asked questions

Who is Takao Honda?

Takao Honda is a corporate venture investor based in Kobe, Hyogo, Japan, listed as Senior Director, Lilly New Ventures, Asia at Eli Lilly and Company. The known portfolio of that firm counts 19 companies. That portfolio belongs to the firm, not to Takao Honda personally.

What does Takao Honda invest in?

Listed sectors include AI and Healthcare; listed focus areas include Biotech, Drug Discovery, Genomics and Machine Learning. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.

What stage does Takao Honda invest at?

Eli Lilly and Company appears in Growth, Late-Stage and Seed rounds across its known deals, and Takao Honda is listed there as Senior Director, Lilly New Ventures, Asia. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.

Which firm is Takao Honda listed at?

Takao Honda is listed as Senior Director, Lilly New Ventures, Asia at Eli Lilly and Company. 23 other people in the database share a firm with Takao Honda.

How do I contact Takao Honda?

A LinkedIn page is on file for Takao Honda. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal